Literature DB >> 24119941

Maternal generalized anxiety disorder during pregnancy and fetal brain development: a comparative study on cord blood brain-derived neurotrophic factor levels.

Faruk Uguz1, Erdem Onder Sonmez, Mine Sahingoz, Zeynel Gokmen, Mustafa Basaran, Kazim Gezginc, Gulsum Sonmez, Nazmiye Kaya, Sami Sait Erdem, Humeyra Cicekler, Erkan Tasyurek.   

Abstract

OBJECTIVES: The study aimed to investigate whether maternal GAD during pregnancy affects fetal circulating brain-derived neurotrophic factor (BDNF), which plays important roles in neuronal development, by comparing cord blood BDNF levels in newborn infants of women with and without GAD.
METHODS: Study sample included 19 women with GAD and 25 women without any psychiatric disorder. GAD and other psychiatric diagnoses were screened by means of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. The blood sample for the determination of BDNF level was obtained from the umbilical cord during delivery.
RESULTS: Cord blood BDNF levels in newborn infants of healthy women were approximately two-fold compared to newborn infants of women with GAD, and the difference was statistically significant. The duration of GAD during pregnancy was the only variable correlating with cord blood BDNF levels.
CONCLUSIONS: The study results imply that prolonged maternal GAD during pregnancy may negatively influence neurodevelopment of the fetus through lower levels of circulating BDNF.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Brain-derived neurotrophic factor; Pregnancy

Mesh:

Substances:

Year:  2013        PMID: 24119941     DOI: 10.1016/j.jpsychores.2013.04.010

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  10 in total

1.  Perinatal Generalized Anxiety Disorder: Assessment and Treatment.

Authors:  Shaila Misri; Jasmin Abizadeh; Shawn Sanders; Elena Swift
Journal:  J Womens Health (Larchmt)       Date:  2015-06-30       Impact factor: 2.681

2.  Determinants of neonatal brain-derived neurotrophic factor and association with child development.

Authors:  Akhgar Ghassabian; Rajeshwari Sundaram; Nikhita Chahal; Alexander C McLain; Erin Bell; David A Lawrence; Edwina H Yeung
Journal:  Dev Psychopathol       Date:  2017-05-02

3.  Prevalence and predictors of anxiety disorders amongst low-income pregnant women in urban South Africa: a cross-sectional study.

Authors:  Thandi van Heyningen; Simone Honikman; Landon Myer; Michael N Onah; Sally Field; Mark Tomlinson
Journal:  Arch Womens Ment Health       Date:  2017-08-29       Impact factor: 3.633

4.  Evaluation of Malondialdehyde, Superoxide Dismutase and Catalase Activity in Fetal Cord Blood of Depressed Mothers.

Authors:  Mehmet Akif Camkurt; Ebru Fındıklı; Murat Bakacak; Fatma İnanç Tolun; Mehmet Fatih Karaaslan
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-02-28       Impact factor: 2.582

5.  Urinary Levels of IL-1β and GDNF in Preterm Neonates as Potential Biomarkers of Motor Development: A Prospective Study.

Authors:  Rafael Coelho Magalhães; Janaina Matos Moreira; Érica Leandro Marciano Vieira; Natália Pessoa Rocha; Débora Marques Miranda; Ana Cristina Simões E Silva
Journal:  Mediators Inflamm       Date:  2017-05-02       Impact factor: 4.711

Review 6.  The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders.

Authors:  A Cattaneo; N Cattane; V Begni; C M Pariante; M A Riva
Journal:  Transl Psychiatry       Date:  2016-11-22       Impact factor: 6.222

7.  Effect of Maternal Depression on Brain-derived Neurotrophic Factor Levels in Fetal Cord Blood.

Authors:  Erdem Onder Sonmez; Faruk Uguz; Mine Sahingoz; Gulsum Sonmez; Nazmiye Kaya; Mehmet Akif Camkurt; Zeynel Gokmen; Mustafa Basaran; Kazim Gezginc; Sami Sait Erdem; Hasan Haluk Dulger; Erkan Tasyurek
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-05-31       Impact factor: 2.582

8.  The placenta protects the fetal circulation from anxiety-driven elevations in maternal serum levels of brain-derived neurotrophic factor.

Authors:  Hayley Dingsdale; Xinsheng Nan; Samantha M Garay; Annett Mueller; Lorna A Sumption; Pedro Chacón-Fernández; Isabel Martinez-Garay; Cedric Ghevaert; Yves-Alain Barde; Rosalind M John
Journal:  Transl Psychiatry       Date:  2021-01-18       Impact factor: 6.222

9.  Evaluation of an Augmented Cognitive Behavioural Group Therapy for Perinatal Generalized Anxiety Disorder (GAD) during the COVID-19 Pandemic.

Authors:  Sheryl M Green; Briar Inness; Melissa Furtado; Randi E McCabe; Benicio N Frey
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

10.  Cognitive-behavioral therapy in pregnant women with generalized anxiety disorder: a retrospective cohort study on therapeutic efficacy, gestational age and birth weight.

Authors:  Faruk Uguz; Mehmet Ak
Journal:  Braz J Psychiatry       Date:  2020-08-03       Impact factor: 2.697

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.